12. januar – (Billede: IO Biotech) Lundbeckfonden øger sit engagement i IO Biotech som led i sin 2030-strategi Lundbeckfonden står med de øvrige nuværende ejere, Novo Holdings og Sunstone sammen om at investere i en ny stor serie B-finansieringsrunde i cancer-selskabet IO Biotech, der tiltrækker nye, markante internationale investorer til dansk biotek. Dermed tager Lundbeckfonden...
Vi bruger cookies for at give dig en bedre brugeroplevelse. Læs mereOK
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.